<p>CHARLESTOWN, Mass., Nov. 22, 2023 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and card
Reuters reporting on the big shunt higher in debt plans, citing German MPs. That is a near doubling. To the extent a portion of it sold offshore will see some EUR buying at the margin.
Leave a Comment